Talcott JA, Siegel R, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. Journal of Clinical Oncology. 1992;10(2):316-22.
Santucci S, Gobara S, Santos C, Fontana C, Levin A. Infections in a burn intensive care unit: experience of seven years. Journal of Hospital Infection. 2003;53(1):6-13.
Lotfi N, Shokohi T, Nouranibaladezaei SZ, Omran AN, Kondori N. High recovery rate of non-albicans Candida
species isolated from burn patients with candidemia in Iran. Jundishapur journal of microbiology. 2015;8(10).
Pfaller M, Diekema D, Jones R, Sader HS, Fluit A, Hollis R, et al. International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program. Journal of Clinical Microbiology. 2001;39(9):3254-9.
Yapar N. Epidemiology and risk factors for invasive candidiasis. Therapeutics and clinical risk management. 2014;10:95.
Zirkel J, Klinker H, Kuhn A, Abele-Horn M, TappeD, Turnwald D, et al. Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors.Medical mycology. 2012;50(1):50-5.
Das I,Nightingale P, Patel M, Jumaa P. Epidemiology, clinical characteristics, and outcome of candidemia: experience
in a tertiary referral center in the UK. International Journal of Infectious Diseases. 2011;15(11):e759-e63.
Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in
United States hospitals: a three-year analysis. Clinical infectious diseases. 1999;29(2):239-44.
VoiculescuM, Iliescu L, Ionescu C,Micu L, Ismail G, Zilisteanu D, et al. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the Sub-Carpathian and South-Eastern regions of Romania. J Gastrointestin Liver Dis. 2010;19(1):43-8.
Yadegarynia D, Fatemi A, Mahdizadeh M, Movahhed RK, Alizadeh MA. Current spectrum of bacterial infections in patients with nosocomial fever and neutropenia. Caspian journal of internalmedicine. 2013;4(3):698.
Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical infectious diseases. 2004;39(3):309-17.
Zorgani A, Franka R, Zaidi M, Alshweref U, Elgmati M. Trends in nosocomial bloodstream infections in a burn intensive care unit: an eight-year survey. Annals of burns and fire disasters. 2010;23(2):88.
Zaoutis T. Candidemia in children. Current medical research and opinion. 2010;26(7):1761-8.
Ghahri M,Mirhendi H, Zomorodian K, Kondori N. Identification and antifungal susceptibility patterns of Candida strains isolated fromblood specimens in Iran. Archives of Clinical Infectious Diseases. 2013;8(3).
Krcmery V, Barnes A. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. Journal of Hospital Infection. 2002;50(4):243-60.
Nicholson A, Rainford L. The epidemiology of fungaemia at the University Hospital of the West Indies, Kingston, Jamaica.West IndianMedical Journal. 2009;58(6):580-4.
Tortorano A, Caspani L, Rigoni A, Biraghi E, Sicignano A, Viviani M. Candidosis in the intensive care unit: a 20-year survey. Journal of Hospital Infection. 2004;57(1):8-13.
Kett DH, Azoulay E, Echeverria PM, Vincent J-L. Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Critical caremedicine. 2011;39(4):665-70.
Labbe A-C, Pepin J, Patino C, Castonguay S, Restieri C, Laverdiere M. A single-centre 10-year experience with Candida bloodstream infections. Canadian Journal of Infectious Diseases and Medical Microbiology. 2009;20(2):45-50.
Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, et al. Clinical practice guidelines for the management candidiasis: 2009 update by the Infectious Diseases Society of America. Clinical infectious diseases. 2009;48(5):503-35.
Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrobial agents and chemotherapy. 2005;49(9):3640-5.
Comments (0)